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We report a case of bilateral cytomegalovirus retinitis in a 12 year-old with neutropenic fever after
maintenance chemotherapy for acute lymphoblastic leukemia. Ophthalmologic examination for photo-
phobia prompted a diagnosis of cytomegalovirus retinitis. With early diagnosis and prompt treatment,
this patient had a favorable visual outcome.
© 2016 Pediatric Hematology Oncology Chapter of Indian Academy of Pediatrics. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Cytomegalovirus (CMV) infection is a major cause of morbidity
and mortality in immunocompromised patients. CMV retinitis is
the most common opportunistic intraocular infection in HIV-
infected adults [1] and can impact any severely immunocompro-
mised patient, including patients who have received a solid organ
or hematopoetic stem cell transplant (HSCT) [2]. In patients with
acute lymphoblastic leukemia (ALL), who undergo less immuno-
suppressive chemotherapy, CMV retinitis has been described in
only two children and one adult [3e5]. We describe a case of
bilateral CMV retinitis in a pediatric patient receiving chemo-
therapy for the treatment of B-lineage ALL.
1. Case report
A 12 year-old male with a history of fetal alcohol syndrome and
B-lineage ALL was treated on Children's Oncology Group protocol
AALL0331 [6] with good response. While he did not haveNew Scotland Avenue MC-24,
tology-Oncology, Albany, NY
ar).
atology Oncology Chapter of
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enses/by-nc-nd/4.0/).candidiasis or other fungal infections throughout therapy, his
clinical course was complicated by seizures, transient methotrexate
leukoencephalopathy and sensitivity to 6-mercaptopurine, leading
to myelosuppression. Two weeks after concluding standard main-
tenance chemotherapy with oral mercaptopurine, methotrexate
andmonthly pulses of vincristine and oral steroid, he was admitted
for neutropenic fever and a focal parenchymal consolidation in the
lung. The patient was noted to have photophobia in both eyes of
two weeks duration and a best-corrected visual acuity (BCVA) of
20/30 OD and 20/50 OS. Anterior chamber examination revealed
1þ white blood cells in both eyes, without ﬂare, ﬁbrin or keratic
precipitates. Fundoscopic examination revealed perivascular white
inﬁltrates along the superior arcades of both eyes and the inferior
arcade of the left eye, and a small retinal hemorrhage nasal to the
optic disc in the right eye (Fig. 1).
Bilateral CMV retinitis was diagnosed and intravenous (IV)
ganciclovir was started. Aqueous tap of the right eye and intra-
vitreal injection of ganciclovir 2 mg/0.1 ml into both eyes was
performed. Serologic testing conﬁrmed the presence of CMV in the
serum as well as in the aqueous ﬂuid by polymerase chain reaction
(PCR). Laboratory studies revealed an absolute CD4 count of
473 cells/mm3 and CD8 count of 1440 cells/mm3. A total of two
intravitreal injections of ganciclovir per eye were administered and
the patient received three weeks of treatment with IV ganciclovirics. Production and hosting by Elsevier B.V. This is an open access article under the
Fig. 1. Fundus photographs of the A. right and B. left eyes at diagnosis and the C. right and D. left eyes post-treatment.
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900 mg daily. After one week, the oral valganciclovir was dis-
continued as the patient developed a maculopapular rash on his
face, chest and trunk. Additionally, cystoid macular edema was
visualized on optical coherence tomography, presumed secondary
to immune recovery uveitis, and nepafenac was started.
At one-month follow-up, the perivascular white inﬁltrates had
resolved and there was pallor of the optic discs and perivascular
retinal pigmentation representing resolution of the retinitis. Over
three years of follow-up his leukemia and retinitis both remain in
remission. The patient developed posterior subcapsular cataracts
that were removed surgically.
2. Discussion
Cytomegalovirus is a member of the herpes virus family of DNA
viruses known to cause a sight-threatening infection of the neural
retina. Although immunosuppressed patients are at risk of devel-
oping disseminated CMV disease, and can present with retinitis,
gastroenteritis, encephalitis and/or pneumonitis, the mildly
immunosuppressive nature of childhood ALL maintenance regi-
mens means that CMV retinitis is typically not encountered in this
population.
In the reported case the patient was brought to ophthalmologic
attention due to a history of photophobia prompting the diagnosis
of CMV retinitis upon dilated fundoscopic exam. In general the
diagnosis of CMV retinitis is based upon clinical suspicion, and the
classic features of CMV retinitis, including perivascular areas of
retinal opaciﬁcation with hemorrhage and retinal necrosis. PCR
testing of the aqueous humor or vitreous can be utilized to establish
a diagnosis, as was conﬁrmed in our case. It is noteworthy that
while ocular specimens accurately reﬂect the status of CMV reti-
nitis, they do not necessarily reﬂect the status of systemic CMV
infection, therefore, a systemic work-up is also necessary.Treatment of CMV retinitis includes either or both systemic and
intravitreal medications. Both IV ganciclovir and foscarnet have
shown efﬁcacy for the treatment of active retinitis, although as both
have signiﬁcant adverse effects, including myelosuppression and
nephrotoxicity, respectively, a ganciclovir implant was developed
[8]. Unfortunately, this implant has been discontinued for ﬁnancial
reasons secondary to the decreasing incidence of CMV retinitis.
Recently, valganciclovir, a prodrug of ganciclovir, has become more
widely used as it is more bioavailable when taken orally [8].
Intravitreal ganciclovir and foscarnet are also effective, although it
is recommended that immunosuppressed patients also receive
systemic therapy as studies have shown reduced mortality and
involvement of the fellow eye [8]. Intravenous cidofovir can also be
used for the treatment of CMV retinitis although a high percentage
of patients can develop medication-related hypotony, uveitis or
nephrotoxicity [9]. Finally, oral leﬂunomide, an anti-inﬂammatory
agent with intrinsic activity against CMV, has shown promise in
ganciclovir resistant cases [10].
Early diagnosis and prompt treatment are among the most
important prognostic factors for CMV retinitis. Additionally, these
patients require close, routine follow-up evaluations, as complica-
tions, such as posterior subcapsular cataracts, can develop and limit
vision. Although, the incidence of CMV retinitis in moderately
immunocompromised children is rare, our case re-conﬁrms that a
high index of suspicion should be maintained and prompt
ophthalmologic referral should be made for any child with ALL
undergoing chemotherapy who develops unexpected visual com-
plaints. The relative lack of symptoms in pediatric patients may
lead to advanced disease and in one study, three of four immuno-
suppressed children diagnosed with advanced CMV retinitis had
bilateral disease, and none of the children (all >36 months of age)
had subjective visual complaints [7]. Fortunately in our case,
despite the advanced stage of the CMV retinitis our patient had a
favorable outcome with aggressive therapy.
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